Abstract
Coronary Artery Disease burden is alarmingly high and is a purpose of challenge. There are many correctable danger factors for CAD. Of these dyslipidemia has the highest danger for myocardial infarction. Of all the lipoproteins, LDL plays a relevant role in CAD. Reduction of LDL-C results in widespread decrease in CAD incidence. However, there are several other atherogenic lipoproteins in the blood like LDL cholesterol-enriched remnants of TG – rich lipoproteins, VLDL, IDL and LDL which accounts for 25%. These are the NON-HDL - C leading to increase in CAD incidence. This study emphasis the importance of non HDL-C in predicting CAD.
Key Words: Coronary Artery Disease (CAD), NON-HDL-Cholesterol.
References
- Katarzyna Bergmann: non HDL cholesterol and evaluation of cardiova-scular risk eJIFCC. 2010;21 (3):181-4 .
- Expert panel on detection, Evaluation and Treatment of high blood cholesterol in adults (ADULT TREATMENT PANEL III) JAMA. 2001; 285 (19):2486-97 .
- Bittner V. Non HDL-C measurement, interpretation and significance. Adv. Stud Med 2007:7(1):8-11.
- Liu J, Sempos C, Donacue RP. Joint distribution of non HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and with diabetes. Diab care. 2005; 28(8):1916-21.
- National Cholesterol Education Program (NCEP) Expert panel on Detection, Evaluation and Treatment of High Blood Cholesterol In Adults final report circulation 2002, 106 :3143-3421.
- Arsenault BJ,Boekholdt SM, Kastelein JJ (2011) Lipid parameters for measuring risk of cardiovascular disease. Nat Rev Cardiol 8: 197-206.
- Pasterkamp C, Falk E (2000) Atherosclerotic plaque rupture: an overview. J Clin Bas Cardiol 3:81-86.
- Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, et al (2001) Non high density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161:1413-1419.
- Ruminska M, Czerwonogrodzka A, Pyrzak B, et al evaluation of non-hdl-c in children and adolescents with abdominal obesity ped pol 2010,1.
- EPIC Norfolk prospective study on Role of NON-HDL cholesterol stratification for coronary artery disease Jamal.S. Rana,S Matthijs Borkholdt (2012) Vol 130-134.
- John J.P. Kastelein, Wim A. Van der steeg, Ingarholme, Michael Gaffney, Nilo BC, Philip Barter, et al. Lipids, Apo lipoproteins and their ratios in relation to cardiovascular events with statin treatment. Circulation. 2008; 117(2): 3002-9.
- Jain Liu, Christopher Sempos, Richard P,Donahue, Joan Dorn, Maurizio Trevisan, Scott M, Grundy: Joint distribution of Non-HDL lipoprotein and coronary artery disease risk prediction among individuals with and without diabetes. Diabetes care 2005;28(8):1961-21.
- Arsenault BJ, Rana JS, Stroes ES, Després JP, Shah PK, Kastelein JJ, et al. Beyond low-density lipoprotein cholesterol: respective contributions of Non- HDL-Cholesterol levels, triglycerides, and the total cholesterol/high density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol. 2009; 55(1):35-41.
- Jain Liu, Christopher Sempos, Richard PD, Joan Dorn, Maurizio Trevisan, Scott MG. Non-HDL Lipoprotein and VLDL cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol. 2006; 98(10):1363-8.
Corresponding Author
J.Sangeetha
Post Graduate, Department of Medicine,
RMMCH, Chidambaram-608002, Tamilnadu
DOI: https://dx.doi.org/10.18535/jmscr/v5i10.82
